Table 1 Anthropometric characteristics and treatment details of the participants.
From: Altered proteome of high-density lipoproteins from paediatric acute lymphoblastic leukemia survivors
Controls | ALL Survivors | |||
|---|---|---|---|---|
All | Healthy | Unhealthy | ||
N (male) | 8 (4) | 16 (8) | 8 (4) | 8 (4) |
Age (years) | 24.2 ± 2.0 | 24.3 ± 1.1 | 23.3 ± 1.6 | 25.4 ± 1.6 |
BMI (kg/m2) | 23.5 ± 0.8 | 25.3 ± 1.6 | 22.3 ± 1.0 | 28.2 ± 2.7 |
Waist circumference (cm) | ||||
Men | 87.0 ± 2.8 | 86.4 ± 4.9 | 79.1 ± 7.4 | 93.8 ± 4.6 |
Women | 80.6 ± 2.7 | 88.1 ± 7.7 | 78.6 ± 2.9 | 97.5 ± 14.5 |
All | 83.8 ± 2.2 | 87.2 ± 4.4 | 78.8 ± 3.7 | 95.6 ± 7.1# |
Age at diagnosis (years) | NA | 8.5 ± 1.3 | 10.9 ± 1.8 | 6.2 ± 1.7# |
Event-free remission (years) | NA | 13.6 ± 1.6 | 10.2 ± 1.1 | 17.1 ± 2.6 |
Treatments | ||||
Chemotherapy only | NA | 2 | 2 | 0 |
Without cardioprotection | NA | 1 | 1 | 0 |
With cardioprotection | NA | 1 | 1 | 0 |
Radiotherapy only | NA | 0 | 0 | 0 |
Chemotherapy + radiotherapy | 12 | 6 | 6 | |
Without cardioprotection | 5 | 1 | 4 | |
With cardioprotection | 7 | 5 | 2 | |
Cranial radiotherapy dose (Gy) | ||||
0 | NA | 2 | 2 | 0 |
12 | NA | 6 | 4 | 2 |
18 | 6 | 2 | 4 | |
Protocol administered | ||||
DFCI 1987-01 | NA | 1 | 0 | 1 |
DFCI 1991-01 | NA | 2 | 0 | 2 |
DFCI 1995-01 | NA | 3 | 2 | 1 |
DFCI 2000-01 | NA | 5 | 4 | 1 |
DFCI 2005-01 | NA | 3 | 2 | 1 |
Risk group | ||||
Standard risk | NA | 12 | 7 | 5 |
High risk | NA | 4 | 1 | 3 |
Corcorticosteroids (mg/m2) | NA | 11921 | 13573 | 10269 |
Active smoking | 0 | 3 | 1 | 2 |
